Publications and Presentations
  • Cirisano FD, Greenspoon JS, Stenson R, Farias-Eisner R, Karlan BY, Lagasse LD: The etiology and management of diarrhea in the gynecologic oncology patient. Gynecol Oncol 50:45-48, 1993.
  • Farias-Eisner RF, Cirisano FD, Grouse D, Leuchter R, Karlan BY, Lagasse LD, Berek JS: Conservative and individualized surgery for early squamous carcinoma of the vulva: The treatment of choice for stages I & II (T1-2 N0-1 M0) disease. Gynecol Oncol 53:55-58, 1994.
  • Farias-Eisner R, Cirisano FD, Berek JS: ACOG human papilloma virus - computer interaction program. American College of Obstetrics and Gynecology Teaching Series,(1994).
  • Karlan BY, Baldwin RL, Cirisano FD, Mamula PW, Jones JJ, Lagasse LD:Secreted ovarian epithelial substance inhibits ovarian epithelial cell proliferation.Gynecol Oncol 59:67-74, 1995.
  • Casey AC, Farias-Eisner R, Pisani AL, Cirisano FD, Kim YB, Muderspach L,Futoran R, Leuchter RS, Lagasse LD, Karlan BY: What is the role of reassessment laparoscopy in the management of gynecologic cancers in 1995? Gynecol Oncol 60:454-61, 1996.
  • Cirisano FD, Lee S, Greenspoon JS:Apparent heparin resistance due to elevated factor VIII in a patient with post-operative deep venous thrombosis: Case Report. J Repro Med 41;3:191-194, 1996.
  • Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, Iglehart JD: Cell Cycle Control of BRCA2 .Cancer Research 56:4590-4594, 1996.
  • Berchuck A, Cirisano FD, Lancaster J, Schildkraut JM, Wiseman RW, Futreal A, Marks JR: Role of BRCA1 mutation screening in the management of familial ovarian cancer. Am J Obstet Gynecol 175:738-746, 1996.
  • Elbendary A, Cirisano FD, Evans AC, Jr., Davis PL, Iglehart JD, Marks JR, Berchuck A: Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 2:1571-1575, 1996.
  • Clifford SL, Kaminetsky CP, Cirisano FD, Dodge R, Soper JT, Clarke-Pearson DL,Berchuck A: Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol 176 (6):S229-S232, 1997.
  • Eachempati SR, Young C, Alexander J, Cirisano FD, Rodriguez GC, Reed II, RL: The use of esophageal doppler monitoring in a patient with early intracardiac Greenfield filter migration. J Vasc Surg (Submitted).
  • Cirisano FD, Soper JT. Clinical management of gestational trophoblastic disease. Primary Care Ob/Gyn. March 1998; In Press.
  • Ng WL, Schummer M, Bumgarner RE, Cirisano, FD, Baldwin RL, Karlan BY and Hood L. High-density cDNA array expression mapping of human ovarian tumors. Proc Amer Assoc Cancer Res 1996; 37: 517.
  • Cirisano FD. Ovarian cancer genetics. Updates from Memorial Regional Cancer Center 1998; 2: 1-6.
  • Cirisano FD. Preinvasive disease of the cervix. Updates from Memorial Regional Cancer Center 1998; 2: 2-13.
  • Cirisano FD. Management of Preinvasive disease of the cervix. Seminars in Surgical Oncology. 1999.
  • Gilliam LK, Scearce RM, Cirisano FD, Lobenhofer E, Marks JR, Hale LP.Production of a monoclonal antibody reactive with BRCA2 protein sequences. Proceedings of the American Association for Cancer Research 1997; 38: 243.
  • Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.
    The role of surgical staging for papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol Submitted.
  • Cirisano FD, Mattox TF, Greenspoon JS:DobyWIN v3.00 computer software patient database application.8 1995 Cirisano, Mattox and Greenspoon.
  • Berchuck A, Cirisano FD: Pathogenesis of ovarian cancer: Role of ovulation and molecular changes. The Ovary: Regulation, Dysfunction and Treatment, (Filicori, M, ed) Elsevier Science B.V., Amsterdam. pp. 267-273, 1996. 
  • Cirisano FD, Karlan BY: The role of HER-2/neu oncogene in gynecologic cancers. J Soc Gynecol Invest 1966;3:99-105, 1996.  
  • Berchuck A, Cirisano FD. Genetics and molecular biology of granulosa-theca cell tumors of the ovary. CME J Gynecol Onc (3) 127-131, 1996. 
  • Cirisano FD, Berchuck A: Current understanding/management of granulosa-theca cell tumors of the ovary. Postgraduate Obstetrics Gynecology 1996.  
  • Berchuck A, Cirisano FD: Genetics of ovarian cancer. The Endocrinologist (in press).  
  • Berchuck A, Cirisano FD: Endometrial carcinoma. Current Therapy in Obstetrics and Gynecology (Zuspan FP, Quilligan EJ eds), 5th Edition. WB Saunders Co, 2000.  
  • Cirisano FD. Ovarian cancer genetics.

©Women's Cancer Care Center LLC 2011. All rights reserved | Designed by Speck Image Inc.